Effects of poly(amidoamine) dendrimers on the structure and function of key blood components

Abstract

Poly(amidoamine) dendrimers have a variety of promising biomedical applications; however, the biological safety of the dendrimers has not been well clarified. This study focuses on the effects of poly(amidoamine) dendrimers (G3, G4, G5, G5–OH) on the structure and function of key blood components, in order to elucidate the impacts of the dendrimers on the aggregation, morphology, lysis of human red blood cells, structural and conformational change as well as polymerization of fibrinogen, and the coagulation of blood tissue. The poly(amidoamine) dendrimers caused aggregation, morphological changes, and lysis of red blood cells, depending on the dendrimer concentration, generation, and surface functional groups. All the dendrimers induced fibrinogen structural and conformational changes, but only cationic dendrimers impaired fibrinogen polymerization ability at high concentrations. In addition, the cationic dendrimers inhibited the activity of clotting factors and fibrinogen in the coagulation of whole blood. Therefore, the surface functional groups, generation, and concentration of the dendrimers play important roles in affecting the structure and function of key blood components. These results provide a critical theoretical basis for the molecular design and clinical application of the poly(amidoamine) dendrimers.

Keywords

Poly(amidoamine) dendrimer hemocompatibility red blood cells fibrinogen

Get full access to this article

View all access options for this article.

References

Pan

Lemmouchi

Akala

. Studies on PEGylated and drug-loaded PAMAM dendrimers. J Bioact Compat Pol 2005; 20: 113–128.

Franchini

Ferruti

. Perspectives on: recent advances in poly(amidoamine)s chemistry. J Bioact Compat Pol 2004; 19: 221–236.

Jevprasesphant

Penny

Jalal

. The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int J Pharm 2003; 252: 263–266.

El-Sayed

Ginski

Rhodes

. Influence of surface chemistry of poly(amidoamine) dendrimers on Caco-2 cell monolayers. J Bioact Compat Pol 2003; 18: 7–22.

Roberts

Bhalgat

Zera

. Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers. J Biomed Mater Res 1996; 30: 53–65.

Han

Chen

Wang

. Blood compatibility of polyamidoamine dendrimers and erythrocyte protection. J Biomed Nanotechnol 2010; 6: 82–92.

Wang

Xiong

Zhu

. Protective effect of PEGylation against poly(amidoamine) dendrimer-induced hemolysis of human red blood cells. J Biomed Mater Res B 2010; 93: 59–64.

Jones

Campbell

Franks

. Cationic PAMAM dendrimers disrupt key platelet functions. Mol Pharm 2012; 9: 1599–1611.

Jones

Campbell

Brooks

. Cationic PAMAM dendrimers aggressively initiate blood clot formation. ACS Nano 2012; 6: 9900–9910.

10.

Dobrovolskaia

Patri

Potter

. Dendrimer-induced leukocyte procoagulant activity depends on particle size and surface charge. Nanomedicine: UK 2012; 7: 245–256.

11.

Dobrovolskaia

Patri

Simak

. Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro. Mol Pharm 2012; 9: 382–393.

12.

Klajnert

Pikala

Bryszewska

. Haemolytic activity of polyamidoamine dendrimers and the protective role of human serum albumin. P Roy Soc A: Math Phy 2010; 466: 1527–1534.

13.

Ziemba

Matuszko

Bryszewska

. Influence of dendrimers on red blood cells. Cell Mol Biol Lett 2012; 17: 21–35.

14.

Domanski

Klajnert

Bryszewska

. Influence of PAMAM dendrimers on human red blood cells. Bioelectrochemistry 2004; 63: 189–191.

15.

Ciolkowski

Rozanek

Szewczyk

. The influence of PAMAM-OH dendrimers on the activity of human erythrocytes ATPases. BBA: Biomembranes 2011; 1808: 2714–2723.

16.

Klajnert

Sadowska

Bryszewska

. The effect of polyamidoamine dendrimers on human erythrocyte membrane acetylcholinesterase activity. Bioelectrochemistry 2004; 65: 23–26.

17.

Zhong

Jiao

Zhang

. Effects of the gene carrier polyethyleneimines on structure and function of blood components. Biomaterials 2013; 34: 294–305.

18.

Zhong

Zhang

. The effect of the gene carrier material polyethyleneimine on the structure and function of human red blood cells in vitro. J Mater Chem B Mater Biol Med 2013; 1: 1885–1893.

19.

Zhang

Zhong

Liu

. Effect of chitosan and carboxymethyl chitosan on fibrinogen structure and blood coagulation. J Biomat Sci: Polym E 2013; 24: 1549–1563.

20.

Shcharbin

Janicka

Wasiak

. Serum albumins have five sites for binding of cationic dendrimers. BBA: Proteins Proteom 2007; 1774: 946–951.

21.

Klajnert

Stanisławska

Bryszewska

. Interactions between PAMAM dendrimers and bovine serum albumin. BBA: Proteins Proteom 2003; 1648: 115–126.

22.

Aggarwal

Hall

McLeland

. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliver Rev 2009; 61: 428–437.

23.

Peng

. Thromboelastographic study of biomaterials. J Biomed Mater Res B 2010; 94: 469–485.

24.

Petroianu

Liu

Maleck

. The effect of In vitro hemodilution with gelatin, dextran, hydroxyethyl starch, or Ringer’s solution on Thrombelastograph. Anesth Analg 2000; 90: 795–800.